Rhesus monkey cerebrospinal fluid amine metabolite changes following treatment with the reversible monoamine oxidase type-A inhibitor cimoxatone-Reference-Cited by-同舟云学术

Rhesus monkey cerebrospinal fluid amine metabolite changes following treatment with the reversible monoamine oxidase type-A inhibitor cimoxatone

Published:1985 Issue:3 Volume:86 Page:265-269
ISSN:0033-3158
Container-title:Psychopharmacology
language:en
Short-container-title:Psychopharmacology

Author:

Garrick Nancy A.,Seppala Timo,Linnoila Markku,Murphy Dennis L.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/BF00432211.pdf

Reference38 articles.

1. Bowers MB Jr (1970) 5-Hydroxyindoleacetic acid in the brain and cerebrospinal fluid of the rabbit following administration of drugs affecting 5-hydroxytryptamine. J Neurochem 17:827?834

2. Burns D, London J, Brunswick DJ, Pring M, Garfinkel D, Rabinowitz JL, Mendels J (1976) A kinetic analysis of 5-hydroxyindoleacetic acid excretion from rat brain and CSF. Biol Psychiatry 11:125?157

3. Dollery CT, Davies DS, Strolin Benedetti M (1982) Clinical pharmacology of MD 780515, a selective and reversible MAO-A inhibitor. In: Kamijo K, Usdin E, Nagatsu T (eds) Monoamine oxidase ? Basic and clinical frontiers. Excerpta Medica, International Congress Series 564, Amsterdam, pp 221?229

4. Dollery CT, Brown MJ, Davies DS, Lewis PJ, Strolin Benedetti M (1983) Oral absorption and concentration-effect relationship of tyramine with and without cimoxatone, a type-A specific inhibitor of monoamine oxidase. Clin Pharmacol Ther 34:651?662

5. Eisler T, Teravainen H, Nelson R, Krebs H, Weise V, Lake CR, Ebert MH, Whetzel N, Murphy DL, Kopin IJ, Calne DB (1981) Deprenyl in Parkinson's disease. Neurology 31:19?23

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship of monoamine oxidase A binding to adaptive and maladaptive personality traits;Psychological Medicine;2010-09-01

2. Animal Models and Procedures for CNS Disorders;Critical Pathways to Success in CNS Drug Development;2010-03-05

3. Toloxatone pharmacokinetics in the plasma and cerebrospinal fluid of the rabbit;Journal of Pharmacy and Pharmacology;1992-02

4. The new generation of monoamine oxidase inhibitors;Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques;1992

5. The behavioral neurobiology of self-injurious behavior in rhesus monkeys;Progress in Neuro-Psychopharmacology and Biological Psychiatry;1990-01